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which our debaters agree, namely the role of incompetent
perforator vein (IPV) interruption in promoting venous ulcer
healing or preventing recurrence. This is consistent with the
Practice Guidelines of the Society for Vascular Surgery and
the American Venous Forum, which recommend “treatment
of pathologic perforating veins that includes those with
outward ﬂow 500-ms duration, with a diameter 3.5 mm,
located beneath healed or open venous ulcer (class C5-C6)”.
1
However, the same document does not recommend treat-
ment of IPVs in patients with simple varicose veins (class
C2), based on a “moderate” level of evidence. This area of
contention has prompted this discussion by the experts,
and it is evident that there are several areas of
disagreement.
In his argument in favor of interruption of IPVs to reduce
varicose vein recurrence, Professor Whitely outlines the
literature describing an association between IPVs and vari-
cose veins but readily admits that a causal relationship has
not been deﬁnitely proven as is the case with venous ul-
cerations. He proposes a common pathophysiology and
shared role of IPVs between venous ulcers and varicose
veins that, he argues, would validate IPV surgery with
varicose veins as it does with venous ulcers. Interruption of
IPVs is possible with a high degree of success (>80%) with
increasingly less invasive techniques, including those pio-
neered by Professor Whitely, but is it necessary? He arguesthat it is necessary and is supported by “overwhelming
circumstantial evidence”.
Dr. O’Donnell counters with the argument that venous
stasis ulcers and varicose veins do not share a common
pathophysiology, and IPVs are not the major cause of
recurrent varicosities, which are a result of the natural
history of the disease itself, irrespective of IPV status.
Regardless, he argues, IPV surgery is not as successful as its
proponents claim, with missed veins and less than optimal
durability.
This leaves us without a deﬁnitive answer. Whereas the
role for perforator vein surgery in advanced venous disease,
or venous ulcers, seems clear, it remains less so with lesser
degrees of disease or varicose veins. Although IPV surgery
can be done with some success via less invasive techniques
the question remains as to whether it has any value in
decreasing the risk of recurrent varicosities. The current
level of evidence does not support its routine use in C2
disease and we should await further evidence prior to
recommending its wider adoption.
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